NGM BIOPHARMACEUTICALS INC Current Liabilities
NGM BIOPHARMACEUTICALS INC had Current Liabilities of $20.08 million as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2024-03-11
- 2023-12-31: Liabilities, Current $20.08M.
- 2023-09-30: Liabilities, Current $22.34M.
- 2023-06-30: Liabilities, Current $28.42M.
- 2023-03-31: Liabilities, Current $37.90M.
| Period end | Liabilities, Current |
|---|---|
| 2023-12-31 | $20.08M 10-K · filed 2024-03-11 |
| 2023-09-30 | $22.34M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $28.42M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $37.90M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $47.84M 10-K · filed 2024-03-11 |
| 2022-09-30 | $48.60M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $42.54M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $44.56M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $61.35M 10-K · filed 2023-02-28 |
| 2021-09-30 | $57.73M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $45.04M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $40.31M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $42.58M 10-K · filed 2022-03-01 |
| 2020-09-30 | $37.72M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $33.70M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $28.46M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $39.72M 10-K · filed 2021-03-15 |
| 2019-09-30 | $40.48M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $38.65M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $42.88M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $41.49M 10-K · filed 2020-03-17 |